Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,500.30 +112.69 0.73%
S&P 500 1,681.87 +12.71 0.76%
Nasdaq 3,520.97 +18.85 0.54%
Ticker Volume Price Price Delta
STOXX 50 2,835.01 +13.36 0.47%
FTSE 100 6,840.27 +36.40 0.53%
DAX 8,530.89 +58.69 0.69%
Ticker Volume Price Price Delta
Nikkei 15,627.30 +246.24 1.60%
Hang Seng 23,261.10 -105.29 -0.45%
S&P/ASX 200 5,165.37 -14.69 -0.28%
  • Exchange: -
  • Sector: Consumer, Non-cyclical
  • Industry: Pharmaceuticals
  • Sub-Industry: Medical-Generic Drugs

C&O Pharmaceutical Technology Holdings Ltd

COPT:SP

Acquired

C&O Pharmaceutical Technology Holdings Ltd (COPT:SP) was acquired by 4507:JP


Company Profile

C&O Pharmaceutical Technology Holdings Ltd. manufactures generic drugs. The Company produces amoxicillin, cefradine and flucloxacilin, and the over-the-counter medicine Ambroxol. C&O markets its products in China.

Advertisement
sec ||= nil